Substituted heteroaryl compounds and methods of use
US10059689B2 · kind B2 · utility
1Cited by
21References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2015 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Feb 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.